Early approval | HZNP Message Board Posts

Horizon Pharma, Inc.

  HZNP website

  • Important Upgrade Notice: 


    At 9 pm Central, Sunday 2/16/2020, we launched the following tools as Phase One of our Premium Plus service (full service package still under development): 

    1) Customizable Scrolling Ticker
    2) Portfolio Manager
    3) Stock-specific News & Trading Email Alert Notifications

    These products are immediately available to Precious Metal & Gemstone Patrons. 

    To watch a tutorial on the "regular" site, click here. On "premium," click here


HZNP   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  1768 of 1777  at  1/21/2020 6:30:15 PM  by

drugfree


 In response to msg 1767 by  drugfree
view thread

Re: Early approval

Notes from Investor call on T.

Expect $30-$40M in net sales for 2020 with most sales in Q4.

$200,000 net pricing per patient.

$14,900 net price per vial.

20 vials avg per patient (75%-80% complete full 6 months)

TW will "re-engage" European authorities on T approval and orphan recognition.

T label leaves it open to a broader population and re treatment. Wouldn't commit to much on this other than to say Optic-x data out early 2021.

One analyst pointed out that guidance of $1B only allows for about 30% of existing population. Questioned why so conservative. TW said would not discuss market share further. My feeling is TW has leaned to under promise and over achieve. The FA failure followed immediately by raising guidance on PC that also went bust caused him to re-think his guidance practices.

AH trading showing better price action.
GL.

Presentation slide show link: https://ir.horizontherapeutics.com/static-files/9058fd29-b307-4d7d-9297-f92e53bf44d6



     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 138
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board






About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...